Back

Urinary sodium as a predictor of loop diuretic therapy post-hospitalization

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Management of acute heart failure: therapeutic approaches and prognosis Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francois Croset

Ramon and Cajal University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Sex-based differences in heart failure management and outcomes: insights from a national cohort of over 600,000 patients
Doctor G. Baudry (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Loop diuretic use before an acute heart failure hospitalization drives natriuretic response but not the efficacy of natriuresis-guided diuretic therapy, a prespecified analysis from the PUSH-AHF trial
Ms L. Zonneveld (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study
Doctor R. de la Espriella (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Hypokalaemia during decongestion with hydrochlorothiazide: the CLOROTIC Trial
Doctor P. Salamanca Bautista (Seville, ES)
Abstract Slides Video
Presentation thumbnail
The clinical outcome comparison of early versus conventional left atrial venting for left ventricular unloading in extracorporeal cardiopulmonary resuscitation patients
Professor M. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Management of acute heart failure: therapeutic approaches and prognosis
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Discussant review - EASY-STOP
thumbnail
Congress Presentation
EASY-STOP: Home urinary sodium monitoring for personalized diuretic titration in heart failure
thumbnail
Congress Presentation
Longitudinal assessment of spot urinary sodium as predictor of clinical outcomes in chronic heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources